EMA reiterates positive recommendation for Eisai-Biogen’s Alzheimer’s drug
The EMA's human medicines committee last year backed Leqembi for a narrower set of patients than those evaluated in a late-stage…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
LEQEMBI
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says…
Leqembi is the only approved treatment in China that has shown efficacy in slowing the progression of Alzheimer’s by directly…
Alzheimer’s drug Leqembi launched by Eisai, Biogen in China
China is the third country to launch LEQEMBI following the US and Japan
USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM…
USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment